Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden,
Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China,
Am J Nephrol. 2023;54(7-8):268-274. doi: 10.1159/000531191. Epub 2023 May 24.
In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients.
In 428 incident dialysis patients (median age 56 years, 62% men, 31% diabetes mellitus, 38% cardiovascular disease [CVD]), plasma IL-6 and albumin were measured at baseline to calculate IAR. We compared the discrimination of IAR with other risk factors for predicting 60-month mortality using receiver operating characteristic curve (ROC) and analyzed the association of IAR with mortality using Cox regression analysis. We divided patients into IAR tertiles and analyzed: (1) cumulative incidence of mortality and the association of IAR with mortality risk in Fine-Gray analysis, taking kidney transplantation as competing risk and (2) the restricted mean survival time (RMST) to 60-month mortality and differences of RMST (∆RMST) between IAR tertiles to describe quantitative differences of survival time.
For all-cause mortality, the area under the ROC curve (AUC) for IAR was 0.700, which was greater than for IL-6 and albumin separately, while for CV mortality, the AUC for IAR (0.658) showed negligible improvement over IL-6 and albumin separately. In Cox regression analysis, IAR was significantly associated with all-cause mortality but not with CV mortality. Both high versus low and middle versus low tertiles of IAR associated with higher risk of all-cause mortality, subdistribution hazard ratio of 2.22 (95% CI 1.40-3.52) and 1.85 (95% CI 1.16-2.95), respectively, after adjusting for age, sex, diabetes mellitus, CVD, smoking, and estimated glomerular filtration rate. ∆RMST at 60 months showed significantly shorter survival time in middle and high IAR tertiles compared with low IAR tertile for all-cause mortality.
Higher IAR was independently associated with significantly higher all-cause mortality risk in incident dialysis patients. These results suggest that IAR may provide useful prognostic information in patients with CKD.
在慢性肾脏病(CKD)患者中,高白细胞介素-6(IL-6)和低白蛋白循环浓度与预后不良相关。我们研究了白细胞介素-6与白蛋白比值(IAR)作为透析患者死亡风险的预测因子。
在 428 例新发病例透析患者(中位年龄 56 岁,62%为男性,31%患有糖尿病,38%患有心血管疾病[CVD])中,基线时测量血浆 IL-6 和白蛋白以计算 IAR。我们使用接受者操作特征曲线(ROC)比较了 IAR 与其他预测 60 个月死亡率的危险因素的鉴别能力,并使用 Cox 回归分析分析了 IAR 与死亡率的关系。我们将患者分为 IAR 三分位数,并分析:(1)死亡率的累积发生率以及 Fine-Gray 分析中 IAR 与死亡率风险的关系,以肾脏移植为竞争风险,(2)到 60 个月死亡率的限制性平均生存时间(RMST)和 IAR 三分位数之间的 RMST 差异(∆RMST),以描述生存时间的定量差异。
对于全因死亡率,IAR 的 ROC 曲线下面积(AUC)为 0.700,大于单独的 IL-6 和白蛋白,而对于心血管死亡率,IAR 的 AUC(0.658)与单独的 IL-6 和白蛋白相比,仅略有改善。在 Cox 回归分析中,IAR 与全因死亡率显著相关,但与心血管死亡率无关。与低 IAR 三分位数相比,高 IAR 三分位数和中 IAR 三分位数与全因死亡率的风险更高相关,亚分布危险比分别为 2.22(95%CI 1.40-3.52)和 1.85(95%CI 1.16-2.95),调整年龄、性别、糖尿病、CVD、吸烟和估计肾小球滤过率后。60 个月时的∆RMST 显示,与低 IAR 三分位数相比,中 IAR 三分位数和高 IAR 三分位数的全因死亡率的生存时间明显更短。
较高的 IAR 与新发病例透析患者的全因死亡率风险显著增加独立相关。这些结果表明,IAR 可能为 CKD 患者提供有用的预后信息。